The characterization of ERBB family mutations in Chinese biliary tract cancers.

被引：0
|
作者：
Song, Tianqiang
Zhang, Wei
Li, Huikai
Chen, Ping
Chen, Xiaoqian
Shi, Junping
Zhang, Shuirong
Yao, Ming
Wang, Kai
机构：
[1] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
[2] OrigiMed, Shanghai, Peoples R China
[3] OrigiMed Inc, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15595
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Genomic determinants and clinical relevance of cancer-associated thrombosis in biliary tract cancers.
    Nichetti, Federico
    Provenzano, Leonardo
    Miliziano, Daniela
    Sposetti, Caterina
    Pircher, Chiara
    Bini, Marta
    Franza, Andrea
    Massa, Giacomo
    Niger, Monica
    Di Bartolomeo, Maria
    De Braud, Filippo G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16179 - E16179
  • [22] Genomic characterization of Chinese biliary tract cancers identifies differences between subtypes and therapeutic biomarkers
    Chen, Xiaofeng
    Pang, Jiaohui
    Liu, Cuicui
    Wang, Sha
    Shao, Yang
    CANCER RESEARCH, 2022, 82 (12)
  • [23] EGFR polymorphisms in bile tract cancers.
    Binder, Marc
    Goekkurt, Eray
    Aust, Daniela
    Mogck, Ulrike
    Brunssen, Coy
    Baretton, Gustavo
    Ehninger, Gerhard
    Stoehlmacher, Jan
    CANCER RESEARCH, 2006, 66 (08)
  • [24] Genomic characterization of biliary tract cancers identifies their driver genes, cell-of-origin, and predisposing mutations
    Nakagawa, Hidewaki
    Wardell, Christopher
    Fujita, Masashi
    Yamada, Toru
    Simbolo, Michele
    Fassan, Matteo
    Karlic, Rosa
    Polak, Paz
    Yamamoto, Masakazu
    Yamaue, Hiroki
    Chayama, Kazuaki
    Miyano, Satoru
    Getz, Gad
    Scarpa, Aldo
    Hirano, Satoshi
    Nakamura, Toru
    HUMAN GENOMICS, 2018, 12
  • [25] Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers.
    Lee, Sunyoung S.
    Cao, Hop Sanderson Tran
    Tzeng, Ching-Wei David
    Metwalli, Zeyad
    Koay, Eugene Jon
    Ludmir, Ethan B.
    Chun, Yun Shin
    Chun, Stephen G.
    Javle, Milind M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] EGFR/ERBB2 aberrations in Chinese biliary tract carcinomas.
    Wu, Xiaobing
    Zhao, Yaping
    Wang, Chenxi
    Ding, Ran
    Deng, Wanglong
    Bu, Fanfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Anthropometric Risk Factors for Cancers of the Biliary Tract in the Biliary Tract Cancers Pooling Project
    Jackson, Sarah S.
    Van Dyke, Alison L.
    Zhu, Bin
    Pfeiffer, Ruth M.
    Petrick, Jessica L.
    Adami, Hans-Olov
    Albanes, Demetrius
    Andreotti, Gabriella
    Freeman, Laura E. Beane
    de Gonzalez, Amy Berrington
    Buring, Julie E.
    Chan, Andrew T.
    Chen, Yu
    Fraser, Gary E.
    Freedman, Neal D.
    Gao, Yu-Tang
    Gapstur, Susan M.
    Gaziano, J. Michael
    Giles, Graham G.
    Grant, Eric J.
    Grodstein, Francine
    Hartge, Patricia
    Jenab, Mazda
    Kitahara, Cari M.
    Knutsen, Synnove F.
    Koh, Woon-Puay
    Larsson, Susanna C.
    Lee, I-Min
    Liao, Linda M.
    Luo, Juhua
    McGee, Emma E.
    Milne, Roger L.
    Monroe, Kristine R.
    Neuhouser, Marian L.
    O'Brien, Katie M.
    Peters, Ulrike
    Poynter, Jenny N.
    Purdue, Mark P.
    Robien, Kim
    Sandler, Dale P.
    Sawada, Norie
    Schairer, Catherine
    Sesso, Howard D.
    Simon, Tracey G.
    Sinha, Rashmi
    Stolzenberg-Solomon, Rachael Z.
    Tsugane, Shoichiro
    Wang, Renwei
    Weiderpass, Elisabete
    Weinstein, Stephanie J.
    CANCER RESEARCH, 2019, 79 (15) : 3973 - 3982
  • [28] Notch family gene mutations associate with high tumor mutational burden in diverse cancers.
    Jiang, Da
    Niu, Zhaojian
    Zhang, Jianli
    Wang, Yanlei
    Shang, Liang
    Li, Bixun
    Guo, Jun
    Wang, Baogui
    Zhao, LingQin
    Wang, Wenjing
    Cui, Qiang
    Pan, Xiaodong
    Hu, Jinwei
    Zhang, Shiyue
    Wang, Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Medical conditions, family history of cancer, and the risk of biliary tract cancers
    Rosato, Valentina
    Bosetti, Cristina
    Dal Maso, Luigino
    Montella, Maurizio
    Serraino, Diego
    Negri, Eva
    La Vecchia, Carlo
    TUMORI JOURNAL, 2016, 102 (03): : 252 - 257
  • [30] Efficacy and biomarker analysis of neoadjuvant carrizumab plus apatinib in patients with local advanced biliary tract cancers.
    Rao, Jian-hua
    Wu, Chen
    Zhang, Hui
    Wang, Xuehao
    Lu, Ling
    Cheng, Feng
    Chen, Dongsheng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345